SCHEMBL3373792

SCHEMBL3373792

O=C(O)Cc1ccc(OCC(=O)N2CCOCC2)cc1

nearest known ligand 0.73

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FKBP1A P62942 8/20 0.73
POLB P06746 1/20 0.68
ALDH1A1 P00352 6/20 0.66
HPGD P15428 3/20 0.64
USP2 O75604 2/20 0.64
SMN1; SMN2 Q16637 3/20 0.61
KDM4E B2RXH2 2/20 0.61
HTT P42858 2/20 0.61
LMNA P02545 1/20 0.61
GAA P10253 1/20 0.58
MAPT P10636 1/20 0.57
MAPK1 P28482 1/20 0.56
RECQL P46063 1/20 0.56
KMT2A Q03164 1/20 0.56
ATM Q13315 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
CYP2C9 P11712 1/20 0.56
GPR183 P32249 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12359393 0.84 FKBP1A (1.00) FKBP1APOLBALDH1A1HPGDUSP2
SCHEMBL8320871 0.84 ALDH1A1 (0.79) FKBP1APOLBALDH1A1HPGDUSP2
SCHEMBL13640045 0.82 FKBP1A (0.80) FKBP1APOLBALDH1A1HPGDUSP2
SCHEMBL13534672 0.81 FKBP1A (0.92) FKBP1APOLBALDH1A1HPGDUSP2
SCHEMBL2712996 0.81 FKBP1A (0.74) FKBP1APOLBALDH1A1HPGDUSP2
SCHEMBL15919449 0.81 FKBP1A (0.74) FKBP1APOLBALDH1A1HPGDUSP2
SCHEMBL9041797 0.81 ALDH1A1 (0.74) FKBP1APOLBALDH1A1HPGDUSP2
SCHEMBL5692472 0.79 ALDH1A1 (1.00) FKBP1APOLBALDH1A1HPGDUSP2
SCHEMBL2554461 0.79 FKBP1A (0.70) FKBP1APOLBALDH1A1HPGDUSP2
SCHEMBL335195 0.79 FKBP1A (0.74) FKBP1APOLBALDH1A1HPGDUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2509566-B2 PROCESS FOR PERMANENT SHAPING OF HUMAN HAIR KAO GERMANY GMBH (DE) 2022-03-09 EP disclosed
EP-2346484-B1 COMPOSITION FOR THE PERMANENT SHAPING OF HUMAN HAIR KAO GERMANY GMBH (DE) 2019-11-06 EP disclosed
EP-2509566-B1 PROCESS FOR PERMANENT SHAPING OF HUMAN HAIR KAO GERMANY GMBH (DE) 2018-08-22 EP disclosed
EP-2424490-B1 COMPOSITION FOR PERMANENT SHAPING OF HUMAN HAIR KAO GERMANY GMBH (DE) 2017-06-28 EP disclosed
EP-2358441-B1 BLEACHING/HIGHLIGHTING COMPOSITION KAO GERMANY GMBH (DE) 2017-06-14 EP disclosed
US-9662289-B2 Process for permanent shaping of human hair KAO GERMANY GMBH (DE) 2017-05-30 US disclosed
US-20170000700-A1 BLEACHING/HIGHLIGHTING COMPOSITION KAO GERMANY GMBH (DE) 2017-01-05 US disclosed
EP-2515844-B1 PROCESS FOR PERMANENT SHAPING OF HUMAN HAIR KAO GERMANY GMBH (DE) 2016-10-26 EP disclosed
US-20140246042-A1 Process for Permanent Shaping of Human Hair KAO GERMANY GMBH (DE) 2014-09-04 US disclosed
US-8753616-B2 Process for permanent shaping of human hair KAO GERMANY GMBH (DE) 2014-06-17 US disclosed
EP-2191863-A1 Composition for the permanent shaping of human hair KPSS-Kao Professional Salon Services GmbH (DE) 2010-06-02 EP disclosed
EP-2191867-A1 Bleaching/Highlighting composition KPSS-Kao Professional Salon Services GmbH (DE) 2010-06-02 EP disclosed
WO-2010046076-A1 COMPOSITION FOR THE PERMANENT SHAPING OF HUMAN HAIR KPSS-KAO PROFESSIONAL SALON SERVICES GMBH (DE) 2010-04-29 WO disclosed
EP-2177206-A1 Composition for the permanent shaping of human hair KPSS-Kao Professional Salon Services GmbH (DE) 2010-04-21 EP disclosed
US-7612212-B2 2-[(S)-2-((S)-2,5-dioxo-4-phenyl-imidazolidin-1-yl)-4-methyl-pentanoylamino]-thiazole-4-carboxylic acid methyl ester; mitogen activated protein/extracellular signal regulated kinase kinase inhibitor; anticarcinogenic agent, cognition activator, nervous and autoimmune system disorders HOFFMANN-LA ROCHE INC. (US) 2009-11-03 US disclosed
EP-1989186-A1 HYDANTOIN BASED KINASE INHIBITORS F.HOFFMANN-LA ROCHE AG (CH) 2008-11-12 EP disclosed
WO-2008101840-A1 COMBINATION OF ERLOTINIB AND MEK-INHIBITORS FOR INHIBITING PROLIFERATION OF TUMOR CELLS F. HOFFMANN-LA ROCHE AG (CH) 2008-08-28 WO disclosed
US-20080207563-A1 METHOD FOR INHIBITING PROLIFERATION OF TUMOR CELLS NIU HUIFENG 2008-08-28 US disclosed
WO-2007096259-A1 HYDANTOIN BASED KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2007-08-30 WO disclosed
US-20070197617-A1 Substituted hydantoins CHEN SHAOQING 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197617-A1 Substituted hydantoins HNMT, HRH3, BRAF FKBP1A 3588/4885POLB 3679/4885ALDH1A1 963/4885
US-20140246042-A1 Process for Permanent Shaping of Human Hair POLR1C, PRKDC, PRKACG FKBP1A 3686/4885POLB 48/4885ALDH1A1 185/4885
US-20170000700-A1 BLEACHING/HIGHLIGHTING COMPOSITION CRYAB, CUTA, CSTB FKBP1A 1587/4885POLB 315/4885ALDH1A1 1560/4885
US-20080207563-A1 METHOD FOR INHIBITING PROLIFERATION OF TUMOR CELLS MKI67, BRAF, MYC FKBP1A 1815/4885POLB 1241/4885ALDH1A1 2822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.